3±268.0) mL vs. (714.1±618.5) mL, p=0.001], and shorter chest tube duration [(3.6±1.7) days vs. (4.2±2.6) days, p=0.014]; however, a similar incidence of chylothorax [3 (2.6%) vs. 7 (6.4%), p=0.207] was recorded. Multivariate logistic regression analysis indicated that neoadjuvant therapy was an independent positive factor of chylothorax (odd ratio [OR] = 9.257; 95% confidence interval [CI] 1.434-59.773, p=0.019); whereas high-volume experience of the surgeon was an independent negative factor of this complication (OR = 0.129; 95% CI 0.017-0.982, p=0.048). Prophylactic fat-free diet does not decrease the incidence of chylothorax after lobectomy. https://www.selleckchem.com/products/hada-hydrochloride.html Further well-designed trials are warranted to verify this occasional finding. Prophylactic fat-free diet does not decrease the incidence of chylothorax after lobectomy. Further well-designed trials are warranted to verify this occasional finding. To explore the efficacy and safety of fast-track surgery (FTS) in the perioperative period of single-hole thoracoscopic radical resection of lung cancer. The clinical data of 152 lung cancer patients undergoing single-hole thoracoscopic radical resection of lung cancer in our hospital from October 2016 to March 2019 were collected. Among them, 76 patients were treated with perioperative FTS (FTS group) following in-depth information and education, effective analgesia, early ambulation and early extubation, while the other 76 patients received conventional perioperative treatments (Control group). The intraoperative volumes of blood loss and fluid infusion in FTS group were smaller than those in Control group. Moreover, the mean time to postoperative drainage tube removal, time to the first postoperative ambulation and length of postoperative hospital stay in FTS group were substantially shorter than those in Control group. Moreover, the visual analog scale (VAS) scores of patients at 48 and 72 h after of hospital stay, reduce hospitalization expense and improve patient's satisfaction, so it is worth clinically applying. This study aimed to investigate the efficacy of platinum drugs in the treatment of elderly patients with advanced non-small cell lung cancer (NSCLC) and their effects on prognosis and survival. A retrospective analysis was performed on the medical records of 128 elderly patients with stage IV NSCLC admitted to Yan'an Affiliated Hospital of Kunming Medical University from January 2015 to February 2016, who were distributed to a combination group (70 patients) and a control group (58 patients) according to chemotherapy. The efficacy was evaluated after 5 cycles of chemotherapy, and the expression levels of cytokeratin 19 fragment antigen (CYFRA21-1) and carcinoembryonic antigen (CEA) before and after chemotherapy were recorded. Patients in the two groups were followed up. Serum CYFRA21-1 and CEA expression levels in the combination group were lower than those in the control group after 3 and 5 cycles of chemotherapy (p<0.05). According to the Response Evaluation Criteria in Solid Tumors (RECIST), aftererefore are worthy of clinical promotion. Currently, more researchers are attracted by the possibility of assessing the sensitivity of a lung tumor to certain chemotherapy drugs and their personalized choice based on an assessment of this sensitivity. The purpose of this study was to explore the prognostic significance of the level of 8 chemosensitivity genes' expression in patients with non-small cell lung cancer (NSCLC). The study included 59 patients with NSCLC IIB-IIIA stage. RNA was isolated from the surgical material of the tumor and normal lung tissue. The expression level of 8 chemosensitivity genes BRCA1, RRM1, ERCC1, TOP1, TOP2a, TUBB3, TYMS, GSTP1 was evaluated using RT-PCR. Cases with higher metastasis-free survival rates showed a significantly low level of expression of the ERCC1, BRCA1, GSTP1 genes (p=0.0004, p=0.01, p=0.01). In addition, analysis of the overall survival revealed that the highest rates were achieved in patients with overexpression of the ERCC1 gene. The overall survival in these patients was 86%, versus 55% in the other group and the differences were statistically significant (p=0.002). No statistically significant differences were found for the remaining genes. Thus, a comprehensive assessment of the chemosensitivity genes expression is important not only from the point of view of understanding the heterogeneity and complexity in the field of molecular biology of NSCLC, but also for a more accurate prognosis and course of the disease. Thus, a comprehensive assessment of the chemosensitivity genes expression is important not only from the point of view of understanding the heterogeneity and complexity in the field of molecular biology of NSCLC, but also for a more accurate prognosis and course of the disease. To investigate the influence of circular ribonucleic acid thrombospondin-1 (circTHBS1) on the proliferation and apoptosis of non-small cell lung cancer (NSCLC) cells by sponging miR-129-5p and regulating the expression of SRY-box transcription factor 4 (SOX4). Carcinoma and para-carcinoma specimens were collected from 40 NSCLC patients, and 25 pairs of specimens were obtained from patients with metastatic and non-metastatic NSCLC. After NSCLC cells were cultured, the proliferation was detected via cell counting kit-8 (CCK-8) and 5-Ethynyl-2'- deoxyuridine (EdU) assays, and the cell cycle and apoptosis rate were analyzed through flow cytometry. Finally, the action targets of circTHBS1 were determined using dual-luciferase reporter gene assay, and Western blotting assay was applied to measure the changes in protein levels. The expression of circTHBS1 was markedly higher in NSCLC patients than that in control group, and it was increased in patients with metastatic NSCLC compared with that in patients with non-metastatic NSCLC. Moreover, the proliferative ability of the cells was weakened notably after transfection with small interfering (Si)-CircTHBS1, but it was enhanced remarkably after transfection with CircTHBS1-overexpression vector (OE). There were complementary sites in circTHBS1 for the 3&#39;-UTR of miR-129-5p, and the fluorescence intensity of wild-type circTHBS1 declined evidently after interacting with miR-129-5p. Besides, there was a putative binding site between miR-129-5p and SOX4, and SOX4 expression was decreased obviously after overexpressing miR-129-5p but increased following overexpression of circTHBS1. CircTHBS1 promotes the proliferation and inhibits the apoptosis of NSCLC cells through targeting miR-129-5p and regulating SOX4 expression. CircTHBS1 promotes the proliferation and inhibits the apoptosis of NSCLC cells through targeting miR-129-5p and regulating SOX4 expression.